Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
BMC Genomics ; 16: 860, 2015 Oct 24.
Article in English | MEDLINE | ID: mdl-26497500

ABSTRACT

BACKGROUND: Moraxella catarrhalis is an important pathogen that often causes otitis media in children, a disease that is not currently vaccine preventable. Asymptomatic colonisation of the human upper respiratory tract is common and lack of clearance by the immune system is likely due to the emergence of seroresistant genetic lineages. No active bacteriophages or prophages have been described in this species. This study was undertaken to identify and categorise prophages in M. catarrhalis, their genetic diversity and the relationship of such diversity with the host-species phylogeny. RESULTS: This study presents a comparative analysis of 32 putative prophages identified in 95 phylogenetically variable, newly sequenced M. catarrhalis genomes. The prophages were genotypically classified into four diverse clades. The genetic synteny of each clade is similar to the group 1 phage family Siphoviridae, however, they form genotypic clusters that are distinct from other members of this family. No core genetic sequences exist across the 32 prophages despite clades 2, 3, and 4 sharing the most sequence identity. The analysis of non-structural prophage genes (coding the integrase, and terminase), and portal gene showed that the respective genes were identical for clades 2, 3, and 4, but unique for clade 1. Empirical analysis calculated that these genes are unexpectedly hyperconserved, under purifying selection, suggesting a tightly regulated functional role. As such, it is improbable that the prophages are decaying remnants but stable components of a fluctuating, flexible and unpredictable system ultimately maintained by functional constraints on non-structural and packaging genes. Additionally, the plate encoding genes were well conserved across all four prophage clades, and the tail fibre genes, commonly responsible for receptor recognition, were clustered into three major groups distributed across the prophage clades. A pan-genome of 283,622 bp was identified, and the prophages were mapped onto the diverse M. catarrhalis multi-locus sequence type (MLST) backbone. CONCLUSION: This study has provided the first evidence of putatively mobile prophages in M. catarrhalis, identifying a diverse and fluctuating system dependent on the hyperconservation of a few key, non-structural genes. Some prophages harbour virulence-related genes, and potentially influence the physiology and virulence of M. catarrhalis. Importantly our data will provide supporting information on the identification of novel prophages in other species by adding greater weight to the identification of non-structural genes.


Subject(s)
Conserved Sequence , Genetic Variation , Genome, Viral , Moraxella catarrhalis/virology , Prophages/genetics , Viral Nonstructural Proteins/genetics , Codon , Computational Biology/methods , Evolution, Molecular , Genomics/methods , Multilocus Sequence Typing , Phylogeny , Prophages/classification , Viral Nonstructural Proteins/chemistry , Viral Proteins/chemistry , Viral Proteins/genetics , Virulence/genetics
2.
Manag Care Interface ; 14(4): 68-80, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11339025

ABSTRACT

Antimicrobial resistance in bacterial respiratory tract pathogens is a rapidly evolving and increasingly disconcerting problem. Major factors that have contributed to resistance are inappropriate prescribing of antibiotics for viral infections and the use of antibiotics with poor activity. The treatment of respiratory tract infections is significantly affected by resistance in organisms such as Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Resistance to beta-lactams, sulfonamides, and macrolides continues to rise. Evidence-based guidelines, founded on clinical and bacteriological outcomes, are imperative to treat patients effectively, to limit the spread of these pathogens, and to minimize further development of resistance. Pharmacokinetic and pharmacodynamic parameters have recently been shown to correlate with clinical outcome, and offer a more rational approach to predicting antimicrobial efficacy and determining clinically relevant susceptibility breakpoints.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Drug Resistance, Microbial , Drug Utilization/standards , Evidence-Based Medicine , Practice Guidelines as Topic , Respiratory Tract Infections/drug therapy , Anti-Bacterial Agents/adverse effects , Anti-Bacterial Agents/classification , Cost of Illness , Disease Management , Haemophilus influenzae/drug effects , Haemophilus influenzae/virology , Humans , Microbial Sensitivity Tests , Moraxella catarrhalis/drug effects , Moraxella catarrhalis/virology , Prevalence , Respiratory Tract Infections/economics , Respiratory Tract Infections/epidemiology , Streptococcus pneumoniae/drug effects , Streptococcus pneumoniae/virology , United States/epidemiology
3.
Infect Immun ; 66(1): 83-8, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9423843

ABSTRACT

We used competitive panning to select a panel of 10 different human antibodies from a large semisynthetic phage display library that distinguish between serum complement-resistant and complement-sensitive strains of the gram-negative diplococcus Moraxella (Branhamella) catarrhalis. Western blotting analyses and inhibition enzyme-linked immunosorbent assays showed that all phage antibodies were directed against the same or closely spaced epitopes on the target protein, which is the high-molecular-weight outer membrane protein (HMW-OMP) of M. catarrhalis. HMW-OMP was found in multiple isolates of complement-resistant but not complement-sensitive M. catarrhalis strains. Nucleotide sequence analysis demonstrated that the immunoglobulin heavy- and light-chain variable-region genes encoding the 10 phage antibodies were remarkably similar, with a strong preference for basic amino acid residues in the heavy-chain CDR3 regions. This is the first report showing that competitive panning is a successful procedure to obtain phage antibodies against differentially expressed structures on phenotypically dissimilar strains of prokaryotic cells.


Subject(s)
Antibodies, Viral/immunology , Bacterial Outer Membrane Proteins/immunology , Bacteriophages/immunology , Complement System Proteins/immunology , Moraxella catarrhalis/immunology , Moraxella catarrhalis/virology , Antibodies, Viral/genetics , Bacteriophages/genetics , Blotting, Western , Enzyme-Linked Immunosorbent Assay , Epitopes/immunology , Flow Cytometry , Immunoglobulin Heavy Chains/genetics , Immunoglobulin Light Chains/genetics , Immunoglobulin Variable Region/genetics , Immunoglobulin Variable Region/immunology , Sequence Analysis, DNA , Sequence Homology, Nucleic Acid
SELECTION OF CITATIONS
SEARCH DETAIL
...